AzTrials
AzTrials

Antibiotic InitiationFIRST AID-LTCNCT03807466

Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term Care

A study testing Dynamic/Interactive vs. Static/Paginated Report and LTC Physicians Enrolled vs. Not Enrolled in Reports in people with Antibiotic Initiation and Antibiotic Duration, run by Institute for Clinical Evaluative Sciences at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is a high rate of inappropriate antibiotic use in long-term care (LTC) facilities, with both unnecessary initiation and prolongation of treatments. Although there are challenges to rational antibiotic use in LTC, the variability in antibiotic initiation and use of prolonged treatment durations is driven by… Read more about this study

Who is it for?
Any age
Conditions the study is for
Antibiotic Initiation, Antibiotic Duration
What is being tested?
Dynamic/Interactive vs. Static/Paginated Report and LTC Physicians Enrolled vs. Not Enrolled in Reports
Could I receive a placebo?
No, everyone receives an active treatment
How many people
356 participants
Where
1 siteCanada
Study dates
15 May 2017to 31 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • An individual having a minimum of 2 records on separate days within the quarter meeting any combination of the following criteria:
  • a record for a non-emergency long-term care inpatient services OR
  • an Ontario Drug Benefits record administered in long-term care
  • Index date = The analysis will be anchored on the most recent of either of the records above within a given quarter or their date of death (whichever date is earliest)

Who cannot join

  • Non-Ontario resident at index date
  • Invalid age (age<19 or age>115) at index date
  • Missing or invalid sex or date of birth at index date
  • Death date is >7 days before index date
  • If the individual does not live in a nursing home or home for the aged
  • Cannot be linked to a Most Responsible Physician (MRP) (see methodology below)
Show all 12Show fewer
  • To Identify the Most Responsible Physician (MRP) Using Virtual Rostering
  • For each patient in the above resident cohort, the study team will retrieve all records from health care providers in the 6 month period preceding the index date (180 days), keeping only records from physicians who have a specialty of 1) general practice, 2) community medicine or 3) geriatrics.
  • Steps for MRP assignment:
  • Step 1) The study team will first select physicians with the highest count of records for the monthly management of a nursing home or home for the aged. This is completed for as many residents as possible.
  • Step 2) If there were no monthly management fee records as described above then the physician with highest count of non-emergency long-term care inpatient services records for each patient will be selected. This step is only applied to residents who could not be matched to a physician by Step 1. Physician must have seen the patient one or more times in 90 days prior to and including index date to be considered MRP. This criteria is applied to ensure the physician has seen the resident within the reporting quarter.
  • Step 3) Some patients will virtually roster to physicians in Enrollment groups, some will virtually roster to physicians that are not in a group. For these, the study team will recode enrollment program type to 'NOR' (not otherwise rostered) - these are likely fee for service physicians.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • ICES

    Toronto, Ontario, M4N 3M5

Other trials in Canada

About this study

Official title: Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term

There is a high rate of inappropriate antibiotic use in long-term care (LTC) facilities, with both unnecessary initiation and prolongation of treatments. Although there are challenges to rational antibiotic use in LTC, the variability in antibiotic initiation and use of prolonged treatment durations is driven by prescriber tendencies rather than resident characteristics. Audit-and-feedback is a well-established intervention to improve professional practices, and is ideally suited for use to improve antibiotic prescribing tendencies in LTC. The literature is saturated with trials indicating benefit of audit-and-feedback, but is in dire need of studies to identify methods to improve the impact of this technique. Health Quality Ontario (HQO), a key partner in the FIRST AID-LTC research program, is already providing audit-and-feedback for other inappropriate prescribing practices in LTC, and has identified antibiotic prescribing as a priority focus.

Read the detailed description

Overarching Goals

The overarching goals of FIRST AID - LTC are two-fold:

  1. Improve rational antibiotic prescribing by physicians to minimize harms among LTC residents.
  2. Advance the science of audit-and-feedback to improve physician prescribing practices.

Specific Aims

To improve rational antibiotic prescribing in LTC:

  1. by decreasing unnecessary initiation of antibiotic treatments among Ontario LTC residents, as well as the variability in initiation rates across LTC prescribers.
  2. by decreasing unnecessary prolonged duration of antibiotic treatments among Ontario LTC residents, as well as the variability in prolonged duration treatment use across LTC prescribers.

To advance audit-and-feedback implementation science:

  1. by evaluating whether a dynamic audit-and-feedback report highlighting antibiotic prescribing can lead to greater reductions in antibiotic use, than a static paginated report

Anticipated Contributions to Health-Related Knowledge

Although the literature is inundated with trials examining the impact of audit-and-feedback compared to usual care, there is a need for studies to improve audit-and-feedback delivery. FIRST AID-LTC will test optimal delivery and peer comparison techniques for audit-and-feedback. The knowledge learned can be extrapolated to antibiotic interventions in LTC in other provinces across Canada, as well more broadly to inappropriate medication prescribing practices in LTC.

Anticipated Contributions to Health Care, Health Systems and Health Outcomes

FIRST AID-LTC will lead to immediate reductions in excess antibiotic use in Ontario LTC facilities, which in turn should result in substantial reductions in direct drug costs, as well as downstream complications of allergy, organ toxicity, C. difficile infections and antimicrobial resistance. With easy transferability to other Canadian provinces, the improvements in cost-savings and patient outcomes could be massive in scope.

Being tested
Dynamic/Interactive vs. Static/Paginated Report, LTC Physicians Enrolled vs. Not Enrolled in Reports

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dynamic/Interactive vs. Static/Paginated ReportBehavioural

    Evaluate whether a stand-alone interactive audit-and-feedback report highlighting antibiotic prescribing can lead to greater reductions in antibiotic use, than a report embedded in a broader static feedback system

  • LTC Physicians Enrolled vs. Not Enrolled in ReportsBehavioural

    Evaluate whether being provided an audit-and-feedback report (regardless of dynamic or static) can lead to greater reductions in antibiotic use, than those who do not receive either report

Study groups in NCT03807466
Study groupRoleWhat they receive
Dynamic/Interactive ReportActive comparatorLTC physician receives dynamic/interactive report only
Receives: Behavioral: Dynamic/Interactive vs. Static/Paginated Report
Static/Paginated ReportNo interventionLTC physician receives static/paginated report only
LTC Physicians Enrolled in ReportsActive comparatorAll LTC physicians who receive a dynamic or paginated report [note: this is not part of randomization assignment, but a quasi-experimental study]
Receives: Behavioral: LTC Physicians Enrolled vs. Not Enrolled in Reports
LTC Physicians Not Enrolled in ReportsNo interventionAll LTC physicians who do not receive a dynamic or paginated report [note: this is not part of randomization assignment, but a quasi-experimental study]

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Antibiotic initiation

    Median % of patients initiated on an antibiotic

    Measured: 3 months

  2. Antibiotic duration

    Median % of antibiotic treatments prolonged >7 days

    Measured: 3 months

Secondary outcomes (5)
  1. ER visit or hospitalization for infection

    The percentage of a LTC physicians' patients that experienced an ER visit or hospitalization due to a potential antibiotic-related harm, including: allergy, general medication adverse event, diarrhea, C. difficile infection, or infection with an antibiotic-resistant organism

    Measured: 3 months

  2. ER visit or hospitalization for antibiotic harms

    To test for harms related to decreased antibiotic use by comparing the percentage of LTC physicians' patients that experience an infection-related ER visit or admission

    Measured: 3 months

  3. Net Clinical impact

    Measure the net clinical impact of the intervention, by comparing all-cause ER visits and hospitalizations and mortality

    Measured: 3 months

  4. Anti-psychotic use

    The percent reduction in anti-psychotic use

    Measured: 3 months

  5. Benzodiazepine use

    The percent reduction in benzodiazepines

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2019
  2. Study start15 May 2017
  3. Primary completion30 Apr 2020
  4. Study completion31 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Assess two interventional parallel study models consisting of two intervention arms each
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
356 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03807466
Sponsor's protocol ID
441-2017
Acronym
FIRST AID-LTC
Status last verified
Aug 2021
First submitted
15 Jan 2019
Last updated
25 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Daneman N, Lee SM, Bai H, Bell CM, Bronskill SE, Campitelli MA, Dobell G, Fu L, Garber G, Ivers N, Lam JMC, Langford BJ, Laur C, Morris A, Mulhall C, Pinto R, Saxena FE, Schwartz KL, Brown KA. Population-Wide Peer Comparison Audit and Feedback to Reduce Antibiotic Initiation and Duration in Long-Term Care Facilities with Embedded Randomized Controlled Trial. Clin Infect Dis. 2021 Sep 15;73(6):e1296-e1304. doi: 10.1093/cid/ciab256.

    PubMed 33754632
  • Laur C, Sribaskaran T, Simeoni M, Desveaux L, Daneman N, Mulhall C, Lam J, Ivers NM. Improving antibiotic initiation and duration prescribing among nursing home physicians using an audit and feedback intervention: a theory-informed qualitative analysis. BMJ Open Qual. 2021 Feb;10(1):e001088. doi: 10.1136/bmjoq-2020-001088.

    PubMed 33547157

Questions about this trial

What is this clinical trial studying?

A study testing Dynamic/Interactive vs. Static/Paginated Report and LTC Physicians Enrolled vs. Not Enrolled in Reports in people with Antibiotic Initiation and Antibiotic Duration, run by Institute for Clinical Evaluative Sciences at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Antibiotic initiation (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03807466, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in